Table 3.

Reasons for antibiotic of choice. Logistic regression models predicting likelihood of choosing fluoroquinolone monotherapy and fortified vancomycin, correcting for location.

Reason	OR	p Value	95% CI lower bound
Fluoroquinolone monotherapy
Efficacy	1.05	0.91	0.45 to 2.46
Coverage	0.30	0.02	0.11 to 0.81
Availability	20.86	<0.001*	6.79 to 64.13
Toxicity	7.48	<0.001*	2.53 to 22.09
Synergy	0.16	0.08	0.02 to 1.23
Resistance	0.39	0.08	0.13 to 1.11
Fortified vancomycin
Efficacy	1.96	0.06	0.97 to 3.92
Coverage	7.10	<0.001*	2.44 to 20.61
Availability	0.20	<0.001*	0.09 to 0.44
Toxicity	0.10	0.003*	0.02 to 0.45
Synergy	0.75	0.56	0.29 to 1.95
Resistance	12.51	<0.001*	4.97 to 31.45

*Statistically significant after Holm-Šídák correction for multiple comparisons.